mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
9e-05 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0002 |
mRNA |
CHEMBL374350 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
mRNA |
ciclosporin |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0009 |
mRNA |
dabrafenib |
GDSC1000 |
pan-cancer |
AAC |
-0.099 |
0.0009 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.16 |
0.001 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
CMK |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.001 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.17 |
0.002 |